Shire Human Genetic Therapies recalls

Shire Human Genetic Therapies has 5 recalls on record with the FDA and USDA, the earliest in 2014 and the latest reported on 2 Oct 2019. The most frequent reason is particulate matter.

Total recalls5since 2014

Last 12 months0reported

Class I5100% of total

Ongoing0latest 2 Oct 2019

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 5 100%Class II 0 0%Class III 0 0%

Why shire human genetic therapies is recalled

Particulate Matter5100%

Product types

Thyroid Medication480%
Injectable & IV Drugs120%

By year

2019480%
2014120%

All shire human genetic therapies recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
2 Oct 2019Drug	CLASS I	Natpara (parathyroid hormone) for Injection recalled	Shire Human Genetic Therapies	Particulate Matter	Nationwide
2 Oct 2019Drug	CLASS I	Natpara (parathyroid hormone) for Injection recalled	Shire Human Genetic Therapies	Particulate Matter	Nationwide
2 Oct 2019Drug	CLASS I	Natpara (parathyroid hormone) for Injection recalled	Shire Human Genetic Therapies	Particulate Matter	Nationwide
2 Oct 2019Drug	CLASS I	Natpara (parathyroid hormone) for Injection, 25 mcg/dose cartridges recalled	Shire Human Genetic Therapies	Particulate Matter	Nationwide
30 Apr 2014Drug	CLASS I	Vpriv¿ (velaglucerase alfa for injection) , Lyophilized Powder recalledVpriv	Shire Human Genetic Therapies	Particulate Matter	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.